Children by choice
MSI Reproductive Choices (MSI) provides sexual and reproductive healthcare services that enable women all over the world to choose whether and when to have children, on their own terms. We have been funding MSI in Senegal since 2019, with an initial focus on mobile operations in the Louga region of Senegal. Since 2021, we have been supporting them across the whole of the country, contributing to their bold objective of serving 1.17 million women by 2024
Women of reproductive age represent one third of Senegal’s population. Only 23% use modern contraceptive methods, with a large disparity between urban and rural areas. Without adequate access to contraception, girls and women are often unable to access or complete an education or pursue a career. Many live in extreme poverty and find it very difficult to look after their large families.
MSI works tirelessly with communities, religious leaders and the government of Senegal to provide access to free, high-quality sexual and reproductive health services for girls and women, such as family planning and cervical cancer screening and treatment.
MSI operates through a network of private centres, mobile outreach teams and community-based services.
Mobile outreach teams work in the most remote communities, where public health services are limited. Knowing that unintended pregnancies force teen girls to drop out of school, special emphasis is placed on providing girl students with counselling and the contraceptive solutions to meet their needs.
Community-based healthcare workers known as MSI Ladies offer door-to-door consultations in urban communities, where cultural barriers require particular discretion.
At national level, MSI supports the government to build public health sector capacity, so that hospitals, clinics and health centres will in the long term be able to fund and provide sexual and reproductive services sustainably on their own.
MSI aims to serve 1,17 million women in Senegal by 2024.
Since MSI first began providing its services in Senegal in 2011, the contraceptive prevalence rate has more than doubled from 13 to 27% (2019). Over 770,000 unintended pregnancies and nearly 2,000 maternal deaths have been averted during the same period.